Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $163.7900 (4.33%) ($154.9800 - $163.7900) on Wed. Jan. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.09% (three month average) | RSI | 98 | Latest Price | $163.7900(4.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 4% a day on average for past five trading days. | Weekly Trend | LGND advances 19% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.545% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-15%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.545% (StdDev 3.09%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $150.82(8.6%) | 10 Day Moving Average | $138.61(18.17%) | 20 Day Moving Average | $121.91(34.35%) | To recent high | 0% | To recent low | 101.2% | Market Cap | $2.632b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |